BVS vs OKE · rev $573.3M vs P/E 15, rev $21.70B
Bioventus Inc (BVS) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
BVS currently screens at market cap $495.1M. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the BVS and OKE stock pages for the full models.
Not investment advice.